LABOR AND INDUSTRIES
Effective Date of Rule: Thirty-one days after filing.
Purpose: This rule making will adopt WAC 296-20-03002 Treatment not authorized, to state that the Charite III disc is not a treatment option for injured workers and victims of crime. L&I reviewed the best scientific evidence on artificial discs and decided not to cover the Charite III disc. This decision was made because there is no substantial scientific evidence to support the disc as a treatment option. The device has not been proven to be safe and efficacious.
Citation of Existing Rules Affected by this Order: Amending WAC 296-20-03002.
Statutory Authority for Adoption: RCW 51.04.020, 51.04.030.
Adopted under notice filed as WSR 06-06-067 on February 28, 2006.
Number of Sections Adopted in Order to Comply with Federal Statute: New 0, Amended 0, Repealed 0; Federal Rules or Standards: New 0, Amended 0, Repealed 0; or Recently Enacted State Statutes: New 0, Amended 0, Repealed 0.
Number of Sections Adopted at Request of a Nongovernmental Entity: New 0, Amended 0, Repealed 0.
Number of Sections Adopted on the Agency's Own Initiative: New 0, Amended 1, Repealed 0.
Number of Sections Adopted in Order to Clarify, Streamline, or Reform Agency Procedures: New 0, Amended 0, Repealed 0.
Number of Sections Adopted Using Negotiated Rule Making: New 0, Amended 0, Repealed 0; Pilot Rule Making: New 0, Amended 0, Repealed 0; or Other Alternative Rule Making: New 0, Amended 0, Repealed 0.
Date Adopted: July 18, 2006.
AMENDATORY SECTION(Amending Order 86-19, filed 2/28/86, effective 4/1/86)
WAC 296-20-03002 Treatment not authorized. The department or self-insurer will not allow nor pay for following treatment:
(1) Use of diapulse, thermatic (standard model only), spectrowave and superpulse machines on workers entitled to benefits under the Industrial Insurance Act.
(2) Iontophoresis; prolotherapy; acupuncture; injections of colchicine; injections of fibrosing or sclerosing agents; and injections of substances other than anesthetic or contrast into the subarachnoid space (intra-thecal injections).
(3) Lumbar artificial disc replacement with Charite lumbar artificial disc.
(4) Treatment to improve or maintain general health (i.e., prescriptions and/or injection of vitamins or referrals to special programs such as health spas, swim programs, exercise programs, athletic-fitness clubs, diet programs, social counseling).
(4))) (5) Continued treatment beyond stabilization of
the industrial condition(s), i.e., maintenance care, except
where necessary to monitor prescription of medication
necessary to maintain stabilization i.e., anti-convulsive,
(5))) (6) After consultation and advice to the
department or self-insurer, any treatment measure deemed to be
dangerous or inappropriate for the injured worker in question.
(6))) (7) Treatment measures of an unusual,
controversial, obsolete, or experimental nature (see WAC 296-20-045). Under certain conditions, treatment in this
category may be approved by the department or self-insurer. Approval must be obtained prior to treatment. Requests must
contain a description of the treatment, reason for the request
with benefits and results expected.
[Statutory Authority: RCW 51.04.020(4) and 51.04.030. 86-06-032 (Order 86-19), § 296-20-03002, filed 2/28/86, effective 4/1/86; 83-16-066 (Order 83-23), § 296-20-03002, filed 8/2/83. Statutory Authority: RCW 51.04.020(4), 51.04.030, and 51.16.120(3). 81-24-041 (Order 81-28), § 296-20-03002, filed 11/30/81, effective 1/1/82; 81-01-100 (Order 80-29), § 296-20-03002, filed 12/23/80, effective 3/1/81; Order 76-34, § 296-20-03002, filed 11/24/76, effective 1/1/77.]